drug development

Welcome to the 'drug development' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'drug development'.

Latest blogosphere posts tagged “drug development”

• Nervy research: Researchers take initial look at ion channels in a model system

  
  Science Blog - Science news straight from the source — Authority: 639
  Before one of your muscles can twitch, before the thought telling it to flex can race down your nerve, a tiny floodgate of sorts -- called an ion channel -- must open in the surface of each cell in these organs to let in the chemical signals that spur the cell to action.
  11 hours ago

• WLF Supports Allergan’s Challenge to FDA’s Policies on Off-Label Speech

  
  FDA Law Blog — Authority: 492
  By Carrie S. Martin –       On November 19, the Washington Legal Foundation (“WLF”), along with three other organizations, filed an amicus curiae brief in support of Allergan, Inc.’s First Amendment challenge to FDA’s ban on “truthful, accurate and nonmisleading speech” proactively ...
  14 hours ago

• A Sapphire Energy Co-Founder Sees Solutions in Algae for Drugs as Well as Biofuels

  
  Xconomy — Authority: 702
  Algae-based technologies , Drug Development , people Denise Gellene wrote: The potential of algae as a clean energy source has been generating a lot of entrepreneurial excitement in San Diego. At last count, 10 local companies are busy working on technologies focused on transforming ordinary pond scum ...
  16 hours ago

• Scripps research study describes new tool in the fight against autoimmune diseases, blood cancers

  
  Science Blog - Science news straight from the source — Authority: 639
  Jupiter, Florida, November 30, 2009 -- A study led by a Scripps Research Institute scientist describes a new, highly pragmatic approach to the identification of molecules that prevent a specific type of immune cells from attacking their host.
  2 days ago

• Scripps research study describes new tool in the fight against autoimmune diseases, blood cancers

  
  Science Blog - Science news straight from the source — Authority: 639
  Jupiter, Florida, November 30, 2009 -- A study led by a Scripps Research Institute scientist describes a new, highly pragmatic approach to the identification of molecules that prevent a specific type of immune cells from attacking their host.
  2 days ago

• Recent Preemption Decisions Offer a Mixed Bag for Generic Drug Manufacturers

  
  FDA Law Blog — Authority: 492
  By Kurt R. Karst –     Returning from the Thanksgiving Holiday, we found our inbox chock-full of recent preemption decisions of note involving generic drugs.  First off is a decision from the U.S. Court of Appeals for the Eighth Circuit in Mensing v. Wyeth .  That case involves generic REGLAN ...
  2 days ago

• Georgia Federal District Court Grants Defendant’s Motion For Summary Judgment in Lanham Act Suit Involving Two Unapproved Drugs

  
  FDA Law Blog — Authority: 492
  By J.P. Ellison –       Earlier this month a federal district court in Georgia granted summary judgment  in a Lanham Act suit that raised a number of FDA issues.  The plaintiff in the suit manufactured two prescription acne products under the trade name Benziq.  Defendant manufactured two products ...
  3 days ago

• Antibiotics - the EU pipeline is empty too

  
  Superbug — Authority: 118
  Weve talked before about the shrinking number of drugs available to treat MRSA and about the challenges of getting new drugs to market . Well, its not just a problem in the United States. A new report from the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency ...
  5 days ago

• It’s time for a ‘third wave’ of malaria activism to tackle drug shortages

  
  West Africa Doctors Network West Africa Doctors Network — Authority: 125
  In this week’s PLoS Medicine, the journal’s editors call for concerted international action to address the crisis of malaria drug shortages across Africa.They argue that there are now signs of an evolving “malaria activism” (akin to AIDS activism), which has scored two big successes. The first wave of malaria ...
  1 week ago

• Would ObamaCare Kill Medical Innovation?

  
  Big Government — Authority: 815
  As health care reform inches closer to reality, a massively important question becomes even more pressing: Will ObamaCare kill the sorts of medical innovation that makes the United States the leader in bringing new treatments, technology, and procedures to market? “America is the only industrialized nation that ...
  1 week ago

• A Week of Woe for Genzyme, A CPR App for Your iPhone, A Better Treatment for Opioid Dependence, and More Boston-Area Life Sciences News

  
  Xconomy — Authority: 702
  Life Sciences , Roundup , Drug Development Wade Roush wrote: Believe it or not, the troubles besetting Genzyme (NASDAQ: GENZ ) were not the only life science stories coming out of the Boston area this week, although they sure grabbed most of the attention. So let’s get them all out of the way first: ...
  1 week ago

• On The Couch… Weekend Reading

  
  Pharmalot — Authority: 587
  Hello, everyone. In between raking leaves, hanging with the short people and walking our faithful friend, we thought it might be helpful to offer you a few minutes of interesting reading. As always, there is much to track. Just the same, we have some errands to run shortly - what the weekend be without running from ...
  2 weeks ago

• Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston-Area Biotechs

  
  Xconomy — Authority: 702
  Life Sciences , Drug Development , biotechnology Ryan McBride wrote: Sanofi-Aventis (NYSE: SNY ) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why Boston-area biotech companies should want to form partnerships with the French drug giant. It was an ...
  3 weeks ago

• Good Things in Threes: Trius Therapeutics Files for IPO to Fund Phase 3 Clinical Trials, Marks San Diego’s Third IPO Filing

  
  Xconomy — Authority: 702
  IPO , Drug-Resistant Infections , Drug Development Bruce V. Bigelow wrote: San Diego’s Trius Therapeutics , a venture-backed biotech developing a new antibiotic for treating acute and life-threatening bacterial infections, submitted a regulatory filing Friday to raise as much as $86 million in an ...
  3 weeks ago

• Gilead (GILD): New potential in 4-in-1 HIV drug

  
  BloggingStocks — Authority: 663
  Filed under: Newsletters , Gilead Sciences (GILD) , Stocks to Buy " Gilead Sciences (NASDAQ: GILD ) develops treatments for life-threatening diseases and specializes in drugs for HIV, the virus that causes AIDS," notes Hannah Choe . The contributing editor to Personal Finance explains, "Already the market ...
  3 weeks ago

• GAO Issues Report on Surrogate Endpoint Accelerated Approvals; Calls for Enhanced Oversight

  
  FDA Law Blog — Authority: 492
  By Kurt R. Karst –       A recent report from the Government Accountability Office (“GAO”), titled “FDA Needs to Enhance Its Oversight of Drugs Approved on the Basis of Surrogate Endpoints,” finds that weaknesses in FDA’s monitoring and enforcement process have hampered the Agency’s ability ...
  3 weeks ago

• Amylin Forms Global Alliance in Obesity Drug Development; TEDMED’s Show Will Go On, Sequenom Sued for Civil Fraud, & More San Diego Biotech News

  
  Xconomy — Authority: 702
  Roundup , Life Sciences , diabetes Bruce V. Bigelow wrote: TEDMED had Martha, Goldie, and other celebrity speakers, but San Diego-based Amylin Pharmaceuticals broke this week’s big news when it signed up a big Japanese partner to develop its line of obesity drugs. It’s all part of your regular dose of ...
  3 weeks ago

• Tiny injector to speed development of new, safer, cheaper drugs

  
  Science Blog - Science news straight from the source — Authority: 639
  Its no bigger than a stamp packet but it has the potential to allow rapid development of a new generation of drugs and genetic engineering organisms, and to better control in-vitro fertilization.
  4 weeks ago

• Supreme Court to Decide Whether an FDA Warning Letter Starts the Statute of Limitations in a Securities Fraud Case

  
  FDA Law Blog — Authority: 492
  By Carrie S. Martin – On November 30, 2009, the United States Supreme Court will hear oral argument in Merck & Co. v. Reynolds , No. 08-905 , a securities class action.  The case concerns the standard of inquiry required to start the clock running on the statute of limitations in a private securities ...
  4 weeks ago

• HPM Posts Summary of H.R. 3962 Provisions Directly Affecting Drug and Device Manufacturers

  
  FDA Law Blog — Authority: 492
  By Alan M. Kirschenbaum & Kurt R. Karst – Last Thursday we reported on the release by the House of H.R. 3962, the health care reform bill that will soon be considered on the House floor.  As we have done with other health care reform proposals, we have prepared a summary of the provisions of H.R. 3962 ...
  4 weeks ago

Comments about drug development